Matthew R Sandbulte

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens
    Matthew R Sandbulte
    Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, MD, USA
    Influenza Other Respi Viruses 3:233-40. 2009
  2. ncbi Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses
    Matthew R Sandbulte
    Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 108:20748-53. 2011

Detail Information

Publications2

  1. ncbi A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens
    Matthew R Sandbulte
    Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, MD, USA
    Influenza Other Respi Viruses 3:233-40. 2009
    ..In addition, the assay is complicated by the need to use virus of a hemagglutinin (HA) subtype novel to the host to detect NA-specific antibodies only...
  2. ncbi Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses
    Matthew R Sandbulte
    Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 108:20748-53. 2011
    ..These data underscore the importance of NA inhibition testing to define antigenic drift when there are sequence changes in NA...